|
|
|||||||||||||||||||||||||||
|
TransEnterix Inc (TRXC) TransEnterix is a medical device company. Co. is focused on the market development for and commercialization of the Senhance® Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance® Surgical System is a multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing haptic feedback, robotic precision, ergonomics, instrumentation including three millimeter microlaparoscopic instruments, eye-sensing camera control and instruments. Co.'s SurgiBot System is a single-port system designed to utilize flexible instruments through articulating channels controlled directly by the surgeon.
|
|
|||||||||||||||||||||||||||
Free TRXC Email Alerts:
TransEnterix Inc (TRXC) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.